leflunomide has been researched along with Co-infection in 1 studies
Leflunomide: An isoxazole derivative that inhibits dihydroorotate dehydrogenase, the fourth enzyme in the pyrimidine biosynthetic pathway. It is used an immunosuppressive agent in the treatment of RHEUMATOID ARTHRITIS and PSORIATIC ARTHRITIS.
leflunomide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 5-methyl-1,2-oxazole-4-carboxylic acid with the anilino group of 4-(trifluoromethyl)aniline. The prodrug of teriflunomide.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Leflunomide (LEF) is an immune modulator used most commonly for rheumatoid arthritis (RA)." | 2.52 | Leflunomide: an immune modulating drug that may have a role in controlling secondary infections with review of its mechanisms of action. ( Germain, M; Smith, KJ, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Smith, KJ | 1 |
| Germain, M | 1 |
1 review available for leflunomide and Co-infection
| Article | Year |
|---|---|
Leflunomide: an immune modulating drug that may have a role in controlling secondary infections with review of its mechanisms of action.
Topics: Adolescent; Adult; Coinfection; Female; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; M | 2015 |